Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree

Abstract. A family presenting several cases of severe primary hypercholesterolaemia and/or premature sudden death was studied. This family is characterized by consanguinity, absence of vertical transmission, bimodal distribution of plasma cholesterol values, and reduction of reproductive fitness in affected individuals. The probands have clinical traits of homozygous familial hypercholesterolaemia, including hypercholesterolaemia, xanthomas and early coronary atherosclerosis, while the parents and grandparents are clinically normal. Eight relatives on the mother's side experienced premature sudden death, and in four cases hypercholesterolaemia was diagnosed. Haplotype segregation analysis of the inheritance of the LDL receptor and apo B genes in the probands' family excluded the involvement of these two genes in the pathogenesis of the disease. LDL receptor activity, as well as the ability of LDL to bind to the LDL receptor, and plasma vegetal sterols were within normal limits both in probands and in their relatives. The study of this pedigree suggests that hypercholesterolaemia is not produced by defects in the LDL receptor or LDL particles, and disease inheritance is consistent with an autosomal recessive trait.

[1]  Craig D. Miller,et al.  Management of Patients With Intramural Hematoma of the Thoracic Aorta , 1993, Circulation.

[2]  G. Schuler,et al.  Regular Physical Exercise and Low‐Fat Diet: Effects on Progression of Coronary Artery Disease , 1992, Circulation.

[3]  R. Hammer,et al.  Cytoplasmic sequence required for basolateral targeting of LDL receptor in livers of transgenic mice , 1992, The Journal of cell biology.

[4]  F. Czubayko,et al.  A simplified micro-method for quantification of fecal excretion of neutral and acidic sterols for outpatient studies in humans. , 1991, Journal of lipid research.

[5]  A. Catapano,et al.  Familial defective apo B‐100, characterization of an Italian family , 1991, European journal of clinical investigation.

[6]  V. Vaccarino,et al.  Aortic and coronary atheromatosis in a woman with severe hypercholesterolaemia without LDL receptor alterations. , 1991, European heart journal.

[7]  H. Hobbs,et al.  Dinucleotide repeat polymorphism at the 3' end of the LDL receptor gene. , 1990, Nucleic acids research.

[8]  H. Hobbs,et al.  A high frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. , 1990, American journal of human genetics.

[9]  E. Boerwinkle,et al.  Rapid typing of apolipoprotein B DNA polymorphisms by DNA amplification. Association between Ag epitopes of human apolipoprotein B-100, a signal peptide insertion/deletion polymorphism, and a 3'flanking DNA variable number of tandem repeats polymorphism of the apolipoprotein B gene. , 1990, Atherosclerosis.

[10]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[11]  H. Hobbs,et al.  Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors. , 1989, The Journal of clinical investigation.

[12]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[13]  M. Mechtel,et al.  Double Msp I RFLP in the human LDL receptor gene. , 1987, Nucleic acids research.

[14]  H. Hobbs,et al.  Human LDL receptor gene: two ApaLI RFLPs. , 1987, Nucleic acids research.

[15]  H. H. Hobbs,et al.  AvaII polymorphism in the human LDL receptor gene , 1987, Nucleic Acids Res..

[16]  Maritha J. Kotze,et al.  A RFLP associated with the low-density lipoprotein receptor gene (LDLR) , 1987, Nucleic Acids Res..

[17]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[18]  S. Grundy,et al.  Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia. , 1985, American journal of medical genetics.

[19]  J. Opitz,et al.  Familial hypercholesterolemia with "normal" cholesterol in obligate heterozygotes. , 1985, American journal of medical genetics.

[20]  C. Sing,et al.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. , 1985, American journal of human genetics.

[21]  G. Miller,et al.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. , 1982, Journal of lipid research.

[22]  A. Gotto,et al.  Pseudohomozygous type II hyperlipoproteinemia. , 1974, The Journal of pediatrics.

[23]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[24]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[25]  A. Sjöholm,et al.  Quantitation of the fourth complement component by electrophoresis in agarose gel containing antibodies. , 1970, Clinical and experimental immunology.

[26]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[27]  H. Hobbs,et al.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia , 1992, Human mutation.

[28]  A. Chakravarti,et al.  Polymorphic DNA haplotypes at the LDL receptor locus. , 1989, American journal of human genetics.

[29]  S. Grundy,et al.  Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Boerwinkle,et al.  Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Wahlefeld.  Triglycerides Determination after Enzymatic Hydrolysis , 1974 .